Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Tecca BaroneSmita DandekarDaniel McKeoneKevin MulieriPublished in: Cancer reports (Hoboken, N.J.) (2024)
Results suggest that the use of allopurinol in pediatric patients with ALL and LLy receiving mercaptopurine during maintenance therapy is both safe and effective.